Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine
Status:
Completed
Trial end date:
2019-08-15
Target enrollment:
Participant gender:
Summary
A case control pharmacokinetic study evaluating the effects of atazanavir-ritonavir on the
pharmacokinetics and toxicity of lumefantrine in people living with HIV attending APIN clinic
of the Lagos University Teaching Hospital
Phase:
Phase 4
Details
Lead Sponsor:
Fogarty International Center of the National Institute of Health
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) National Institute on Minority Health and Health Disparities (NIMHD) NIH Office of AIDS Research (OAR)
Treatments:
Artemether Artemether, Lumefantrine Drug Combination Atazanavir Sulfate Lumefantrine Ritonavir